Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of Methylphenidate Hydrochloride as a Treatment for Chronic Fatigue Syndrome in Patients Taking a CFS-Specific Nutrient Formula

NCT01966276 is registered in ClinicalTrials.gov with K-PAX Pharmaceuticals, Inc. as lead sponsor.

NCT NCT01966276
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01966276 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of Methylphenidate Hydrochloride as a Treatment for Chronic Fatigue Syndrome in Patients Taking a CFS-Specific Nutrient Formula
Lead sponsor
K-PAX Pharmaceuticals, Inc.
Phase
Phase 2
Overall status
Unknown status
Start date
November 30, 2013
Completion date
December 31, 2014
Enrollment
134 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

chronic fatigue syndrome (cfs), myalgic encephalomyelitis (me)